During the past decade, Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1" are "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials). Many other conditions were trialed in "Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1" in a lesser frequency.

Most popular intervention types in "Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pimavanserin" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".